Costs and effects of secondary prevention with perindopril in stable coronary heart disease in Poland - an analysis of the EUROPA study including 1251 Polish patients

W. Ken Redekop, Ewa Orlewska, Pawel Maciejewski, Frans F. H. Rutten, Louis W. Niessen

Research output: Contribution to journalArticle

8 Citations (Scopus)
Original languageEnglish
Pages (from-to)861-877
Number of pages17
JournalPharmacoEconomics
Volume26
Issue number10
DOIs
Publication statusPublished - 2008

Cite this